- Home
- FLUX vs ICU Comparison
FLUX vs ICU Comparison
Compare FLUX & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- ICU
- Stock Information
- Founded
- FLUX N/A
- ICU 2018
- Country
- FLUX United States
- ICU United States
- Employees
- FLUX N/A
- ICU N/A
- Industry
- FLUX Industrial Machinery/Components
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- ICU Health Care
- Exchange
- FLUX Nasdaq
- ICU Nasdaq
- Market Cap
- FLUX 30.0M
- ICU 25.6M
- IPO Year
- FLUX N/A
- ICU N/A
- Fundamental
- Price
- FLUX $1.49
- ICU $0.79
- Analyst Decision
- FLUX Strong Buy
- ICU
- Analyst Count
- FLUX 2
- ICU 0
- Target Price
- FLUX $6.00
- ICU N/A
- AVG Volume (30 Days)
- FLUX 140.6K
- ICU 1.4M
- Earning Date
- FLUX 05-08-2025
- ICU 08-13-2025
- Dividend Yield
- FLUX N/A
- ICU N/A
- EPS Growth
- FLUX N/A
- ICU N/A
- EPS
- FLUX N/A
- ICU N/A
- Revenue
- FLUX $63,074,000.00
- ICU $766,000.00
- Revenue This Year
- FLUX $10.96
- ICU $894.81
- Revenue Next Year
- FLUX $12.78
- ICU $71.78
- P/E Ratio
- FLUX N/A
- ICU N/A
- Revenue Growth
- FLUX N/A
- ICU N/A
- 52 Week Low
- FLUX $1.15
- ICU $0.31
- 52 Week High
- FLUX $3.48
- ICU $5.79
- Technical
- Relative Strength Index (RSI)
- FLUX 39.70
- ICU 48.18
- Support Level
- FLUX $1.63
- ICU $0.81
- Resistance Level
- FLUX $1.88
- ICU $0.92
- Average True Range (ATR)
- FLUX 0.15
- ICU 0.07
- MACD
- FLUX -0.02
- ICU -0.00
- Stochastic Oscillator
- FLUX 4.44
- ICU 20.11
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.